In its impact study, Inno TSD showed that Genopole, the 1st French biocluster, makes a strong contribution to innovation, economic development and the attractiveness of the territory (more than 5,600 jobs created or maintained).
Genopoly represents the 1st French biocluster and a European benchmark in biotechnologies and biotherapies, in particular around genomics. Based on a unique approach, combining Scientific Park and Cluster, Génopole welcomes, connects and supports researchers and companies and constitutes a dynamic ecosystem promoting synergies and cooperation likely to bring out the next scientific and industrial advances in the field of health .
Impact study conducted by inno TSD and Collaborative People has shown that Génopole is a major player for attractiveness and economic development, particularly in the southern Paris region, with more than 5,600 jobs created or maintained (direct, indirect and induced) and the creation / establishment 8 companies with high technological content per year (on average). Génopole has also made it possible, thanks to its infrastructures and research laboratories, to support research and innovation (around 1,000 publications between 2015 and 2017 in public laboratories) and allows the emergence of new generations of talent, in particular with the University of 'Evry Val-d'Essonne.
These positive impacts are significant even though Génopole now aims to change scale by 2025 with plans to extend its capacity to accommodate laboratories and companies.